Laurent Humeau
Technik-/Wissenschafts-/F&E-Leiter bei INOVIO PHARMACEUTICALS, INC.
Vermögen: 246 412 $ am 30.04.2024
Aktive Positionen von Laurent Humeau
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.02.2014 | - |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Direktor/Vorstandsmitglied | 12.10.2022 | - |
Karriereverlauf von Laurent Humeau
Ehemalige bekannte Positionen von Laurent Humeau
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - | - |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | - |
Ausbildung von Laurent Humeau
Statistik
International
| Vereinigte Staaten | 5 |
| Frankreich | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
| Université Paris Diderot-Paris 7 | Consumer Services |
| Université Pierre et Marie Curie | Consumer Services |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
- Börse
- Insiders
- Laurent Humeau
- Erfahrung
